Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (3296)	11/1/1997 4:34:00 PM
From: chirodoc	Read Replies (1) \| Respond to of 9719

<<<<<They have a number of alliances, have to see how they play out. .........i agree--the concept of great tasting medicine is definitely a great niche. i can vouch for this everytime i need to give our dogs their pills. :-) .......i just hope a big pharma doesn't pull a msft/netscape and decide to copy their concept and drive them to their knees. ...... the fact that they are this far along and are (i think) working on an ibprofen compound which should be ready soon is positive. ....good tasting generics could be a great beach head to land on.